Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized 64Cu-Intraperitoneal Radioimmunotherapy against Peritoneal Dissemination of Pancreatic Cancer: A Feasibility Study.
Hihara F, Matsumoto H, Yoshimoto M, Masuko T, Endo Y, Igarashi C, Tachibana T, Shinada M, Zhang MR, Kurosawa G, Sugyo A, Tsuji AB, Higashi T, Kurihara H, Ueno M, Yoshii Y. Hihara F, et al. Among authors: shinada m. Int J Mol Sci. 2022 May 22;23(10):5807. doi: 10.3390/ijms23105807. Int J Mol Sci. 2022. PMID: 35628616 Free PMC article.
Evaluation of Aminopolycarboxylate Chelators for Whole-Body Clearance of Free 225Ac: A Feasibility Study to Reduce Unexpected Radiation Exposure during Targeted Alpha Therapy.
Yoshimoto M, Yoshii Y, Matsumoto H, Shinada M, Takahashi M, Igarashi C, Hihara F, Tachibana T, Doi A, Higashi T, Fujii H, Washiyama K. Yoshimoto M, et al. Among authors: shinada m. Pharmaceutics. 2021 Oct 16;13(10):1706. doi: 10.3390/pharmaceutics13101706. Pharmaceutics. 2021. PMID: 34683999 Free PMC article.
Preclinical Safety Evaluation of Intraperitoneally Administered Cu-Conjugated Anti-EGFR Antibody NCAB001 for the Early Diagnosis of Pancreatic Cancer Using PET.
Matsumoto H, Igarashi C, Tachibana T, Hihara F, Shinada M, Waki A, Yoshida S, Naito K, Kurihara H, Ueno M, Ito K, Higashi T, Yoshii Y. Matsumoto H, et al. Among authors: shinada m. Pharmaceutics. 2022 Sep 12;14(9):1928. doi: 10.3390/pharmaceutics14091928. Pharmaceutics. 2022. PMID: 36145676 Free PMC article.
Pan-tumour analysis of COX-2 expression in dogs.
Eto S, Shinada M, Saeki K, Tsuboi M, Kamoto S, Yoshitake R, Chambers J, Uchida K, Kato D, Nishimura R, Nakagawa T. Eto S, et al. Among authors: shinada m. Vet J. 2024 Apr;304:106064. doi: 10.1016/j.tvjl.2024.106064. Epub 2024 Jan 17. Vet J. 2024. PMID: 38242282
Podoplanin promotes cell proliferation, survival, and migration of canine non-tonsillar squamous cell carcinoma.
Shinada M, Kato D, Tsuboi M, Ikeda N, Aoki S, Iguchi T, Li T, Kodera Y, Ota R, Koseki S, Shibahara H, Takahashi Y, Hashimoto Y, Chambers JK, Uchida K, Noguchi S, Kato Y, Nishimura R, Nakagawa T. Shinada M, et al. J Vet Med Sci. 2023 Oct 18;85(10):1068-1073. doi: 10.1292/jvms.23-0062. Epub 2023 Aug 4. J Vet Med Sci. 2023. PMID: 37544715 Free PMC article.
Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma.
Shinada M, Kato D, Motegi T, Tsuboi M, Ikeda N, Aoki S, Iguchi T, Li T, Kodera Y, Ota R, Hashimoto Y, Takahashi Y, Chambers J, Uchida K, Kato Y, Nishimura R, Nakagawa T. Shinada M, et al. Mol Cancer Res. 2023 Nov 1;21(11):1205-1219. doi: 10.1158/1541-7786.MCR-22-0929. Mol Cancer Res. 2023. PMID: 37493578
48 results